Drug Design Group BY

Belarusian computational drug design research group within the United Institute of Informatics Problems of the National Academy of Sciences of Belarus in Minsk, whose stated aim is to speed up drug discovery and development. Applies molecular modelling, molecular dynamics, virtual screening, machine learning and deep learning to identify small drug like compounds against therapeutic targets, with published work on HIV-1 entry inhibitors and inhibitors of the SARS-CoV-2 main protease, and collaborates with Belarusian and international laboratories on target based discovery.